S

Synendos Therapeutics AG

9 employees

Synendos Therapeutics develops a class of small molecules for the treatment of anxiety and stress-related disorders.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Health Care
Therapeutics
Medical

Date founded

2019

Funding rounds raised

Total raised

$26M

from 9 investors over 9 rounds

S

Synendos Therapeutics AG raised $26M on April 20, 2021

Investors: Ysios Capital

S

Synendos Therapeutics AG raised $22M on November 12, 2020

Investors: Lichtsteiner Foundation, Essential Investment Partners, LLC, Zürcher Kantonalbank, High-Tech Gründerfonds and Sunstone Life Science Ventures

S

Synendos Therapeutics AG raised $100K on October 15, 2019

Investors: Venture Kick

S

Synendos Therapeutics AG raised $40K on May 22, 2019

Investors: Venture Kick

S

Synendos Therapeutics AG raised $10K on December 11, 2018

Investors: Venture Kick

FAQ